These data are well in line with the results of previous pharmacogenetic studies in East-Asian populations with variable starting doses [9, 10, 22], reaffirming the association between NUDT15 R139C and AZA-induced toxicity in Chinese IBD patients. The gene discussed is NUDT15; the disease is inflammatory bowel disease.